• SR 11302: AP-1 Transcription Factor Inhibition

  2026-08-09

  SR 11302 enables selective AP-1 pathway interrogation without directly activating retinoid receptors. This practical guide connects tumor-cell assays with macrophage-polarization research to support chemoprevention, chemotherapy, and inflammation-associated cancer studies.

• DdmDE-Mediated Plasmid Clearance: Mechanistic Insights

  2026-08-08

  Yang et al. show that the bacterial DdmDE defense module clears plasmids through a dynamic sequence of target sampling, DdmD-driven bidirectional DNA unwinding, single-stranded DNA extrusion, and cleavage. The study reframes prokaryotic Argonaute defense as a cooperative mechanical process in which target recognition and nuclease activity are functionally separated.

• Vancomycin Hydrochloride: Assay Design Guide

  2026-08-07

  Vancomycin hydrochloride is more than a routine Gram-positive control: its defined cell-wall target makes it a powerful anchor for interpreting antibiotic resistance assays and engineered antimicrobial-peptide studies. This guide connects molecular mechanism, orthogonal readouts, formulation choices, and translational model design.

• Treponema pallidum Triggers Hepatocyte Apoptosis via Mitocho

  2026-08-07

  This study demonstrates that Treponema pallidum induces intrinsic apoptosis in hepatocytes by promoting mitochondrial ROS accumulation and cardiolipin peroxidation. The findings clarify the mitochondrial mechanisms underlying liver injury in syphilis and offer methodological insights for cell death mechanism research.

• Indole-3-pyruvic Acid (IPA): Reliable Solutions for Immune a

  2026-08-06

  This article explores how Indole-3-pyruvic acid (SKU C8759) from APExBIO addresses key laboratory challenges in cell viability, immune modulation, and plant hormone research. Practical, literature-backed protocols and scenario-driven insights help biomedical researchers and lab technicians ensure data reproducibility and experimental reliability.

• EPI-001: Redefining Androgen Receptor NTD Inhibition in CRPC

  2026-08-06

  Explore how EPI-001, a potent androgen receptor N-terminal domain inhibitor, offers a unique approach to castration-resistant prostate cancer (CRPC) research. This article delivers advanced mechanistic insights, protocol guidance, and a nuanced perspective on EPI-001’s role in overcoming resistance mechanisms.

• O-GlcNAcylation Links Wnt Signaling to Bone Formation via Gl

  2026-08-05

  This study uncovers how Wnt signaling stimulates bone formation by promoting O-GlcNAcylation, a post-translational modification that rewires aerobic glycolysis in osteoblasts. The findings reveal a mechanistic bridge between Wnt pathway activation and metabolic control in bone anabolism, offering new avenues for targeted osteoporosis research.

• Obeticholic Acid: Applied Workflows for Liver Fibrosis Resea

  2026-08-05

  Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid) offers researchers a robust tool for dissecting FXR-mediated pathways in liver fibrosis, inflammation, and metabolic regulation. This article translates recent mechanistic discoveries into actionable workflows, troubleshooting insights, and advanced applications for translational hepatic research.

• Procainamide Hydrochloride: Cardiac Sodium Channel Blockade

  2026-08-04

  Procainamide Hydrochloride is a prototypical cardiac sodium channel blocker with validated antiarrhythmic, anti-inflammatory, and epigenetic activities. Its efficacy in ventricular arrhythmia research and cisplatin-induced hepatotoxicity models is supported by robust animal and bench data. Recent studies extend its relevance to combinatorial oncology workflows.

• CH 223191: Precision Aryl Hydrocarbon Receptor Antagonist Wo

  2026-08-04

  CH 223191 empowers researchers to dissect AhR-driven pathways with reproducible precision, enabling advanced studies in environmental toxicology and mucosal repair. This article translates bench research and literature into actionable workflows, troubleshooting guidance, and protocol enhancements for optimized experimental outcomes.

• MDV3100 (Enzalutamide): Optimizing Prostate Cancer Assays

  2026-08-03

  MDV3100 (Enzalutamide) unlocks precision in dissecting androgen receptor signaling and resistance mechanisms in castration-resistant prostate cancer models. This article charts robust experimental workflows, highlights advanced use-cases, and provides troubleshooting strategies, all rooted in the latest mechanistic and translational insights.

• Surrogate Barrier Model Enhances CNS Drug Permeability Predi

  2026-08-03

  Hu et al. (2025) introduce a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating a lysosomal trapping correction to improve prediction of CNS drug permeability. This surrogate system demonstrates close alignment with in vivo brain drug distribution, streamlining early-stage screening for brain-penetrant therapeutics.

• Golgi-Tracker Green: Advancing Live-Cell Golgi Apparatus Lab

  2026-08-02

  Golgi-Tracker Green leverages BODIPY FL-labeled C5-ceramide chemistry to deliver highly specific and photostable live-cell Golgi imaging, surpassing conventional probes. Its workflow adaptability and superior performance empower reliable sphingolipid metabolism and lipid transport studies in dynamic cellular environments.

• Viral Regulation of RIPK3 Degradation Shapes Inflammation Co

  2026-08-01

  Liu et al. identify a conserved orthopoxviral protein class that induces ubiquitin-proteasome-mediated degradation of RIPK3, inhibiting necroptosis and modulating virus-induced inflammation. This mechanistic insight advances our understanding of pathogen-host interactions and informs experimental strategies for studying regulated cell death.

• Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X

  2026-07-31

  The Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) prevents protein degradation and dephosphorylation during sample preparation, protecting protein integrity for downstream analysis. It is recommended for workflows where EDTA is undesirable, such as studies involving metalloproteins or metal-dependent enzymes. This product should not be used in assays requiring EDTA-mediated chelation.

14564 records 2/971 page Previous Next 12345 下5页 Last page